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Background. The prognosis of unexplained chest pain
patients provides valuable information for evalua-
tion of health services.
Objective. To examine prognosis of unexplained chest
pain.
Methods. Using data from in- and outpatient hospital
visits in Norway of patients discharged with a main
diagnosis of unexplained chest pain (ICD-10:
R072–R074) in 2010–2012, the 1-year incidence
of coronary heart disease (CHD), any cardio-vas-
cular disease (CVD) and mortality was evaluated.
Cases with prior 2-year history of CVD or chest
pain were excluded. Cox proportional hazards
evaluated outcomes by patient characteristics
and standardized mortality ratios evaluated
observed versus expected mortality.
Results. Of 59 569 patients identified (20–89 years of
age), the majority (86%) were referred to hospital by
out-of-hours emergency care centres. Subsequent
CHD was noted for 12.5%, 19.5% and 25.0% of
men and 7.2%, 11.0%, 14.0% of women aged 45–
64, 65–74 and 75–89 years, respectively. The per
cent of deaths attributed to CVD were greatest
within the first 2 months of postdischarge. Total
mortality rates (per 1000 person-years) were 6.6 in
men and 4.7 in women aged 45–64 and 69.2 in
men and 39.5 in women aged 75–89 years. Relative
to the general population, mortality was 53% and
45% higher for men and women under 65 years of
age, respectively, attributed primarily to non-CVD
causes.
Conclusion. Patients in Norway discharged with unex-
plained chest pain are an at-risk group in terms of
incident CHD, any CVD and mortality, including
non-CVD mortality during the first-year postdis-
charge. The results suggest that unexplained chest
pain patients may benefit from greater healthcare
coordination between medical disciplines.
Keywords: cardiovascular disease, chest pain, inci-
dence, mortality, socio-economic status.
Introduction
Chest pain is a common adult symptom [1–4], and
patients presenting with chest pain represent a
significant burden to emergency departments [5].
In the US, chest pain accounted for 38% of
noninjury emergency department visits between
2007 and 2008 where acute coronary syndrome
was identified for only 13% of the patients with
chest pain [6]. The primary concern for practition-
ers has been identifying underlying coronary heart
disease (CHD) and preventing life-threatening
events such as myocardial infarction. Excessive
diagnostic procedures, on the other hand, incur
costs and utilize the time of healthcare personnel
[7]. Chest pain in 40% of patients [8] or more [9,10]
indicates the presence of noncardiac causes [11–
15], primarily reflecting gastro-oesophageal dis-
orders, psychological distress/anxiety and respi-
ratory disease.
The evaluation of the prognosis of patients with
chest pain can provide valuable insight of the
healthcare needs of this patient group and help
guide the planning of healthcare services. We,
therefore, evaluated the 1-year morbidity and
mortality of patients discharged from hospital with
an incident diagnosis of unexplained chest pain in
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Norway. Further, we compared 1-year mortality of
the patient population to that of the general pop-
ulation.
Materials and methods
The study is a component of the research project,
‘Patients with Cardiovascular Disease in Norway,
2008–2012’ approved by Region North (2012/
1005) of the Regional Committees for Medical and
Health Research Ethics.
Patients
Patients discharged from hospital or outpatient
clinics with a main diagnosis of unexplained chest
pain (International Classification of Diseases, ICD-
10: R07.2 ‘Precordial pain’, R07.3 ‘Anterior chest-
wall pain NOS’ and R07.4 ‘Chest pain, unspecified’)
were identified through the ‘Cardiovascular Dis-
ease (CVD) in Norway 2008-2012’ project with
details published elsewhere [16]. Data were
obtained from the Norwegian Patient Registry, the
Cause of Death Registry and the National Educa-
tional Database of Statistics Norway. The National
Registry provided census data. The Norwegian
Patient Registry includes data on hospital inpatient
and outpatient visits with information on diag-
noses and medical/surgical procedures performed
during the hospital visit.
Exclusions
A total of 144 261 patients were identified with a
main discharge diagnosis of unexplained chest
pain during 2008–2012. We used a 2-year look
back period where patients with a prior main or
secondary CVD diagnosis (ICD-10: I00–I99;
n = 43 666) or an unexplained chest pain diagno-
sis during 2008–2009 (n = 30 800) were excluded.
Further, patients with a secondary diagnosis of
unexplained chest pain in 2010–2012 (n = 4284)
were excluded from the prospective analyses. In
addition, we excluded patients under 20 and over
89 years of age at time of their first hospital
discharge with chest pain during 2010–2012
(n = 2245), and patients without a national per-
sonal identification number (n = 1831). Finally,
those who had a secondary CHD diagnosis noted
at the time of discharge with unexplained chest
pain as the main diagnosis during 2010–2012
(n = 1866) were excluded. After exclusions, data
on 59 569 patients remained for analyses of prog-
nosis (Figure S1, Flow chart). The 59 569 patients
provided a maximum of 48 259 person-years of
follow-up where the discrepancy in number of
patients versus person-years largely reflected
unequal lengths of observation time resulting from
patients whose first discharge with unexplained
chest pain occurred late in the third year of the
study period (i.e. they could not contribute a full
year of observation).
Outcomes
We evaluated the extent to which patients received
diagnostic procedures within 180 days after dis-
charge with unexplained chest pain as the main
diagnosis (index event). Procedures were identified
through F-coded procedures in a prior version of
the NOMESKO Nordic Classification of Medical
Procedures (NCMP) involving coronary angiogra-
phy and echocardiography (https://finnkode.ehe
lse.no/#ncmpncsp/0/0/0/-1).
We further evaluated the 1-year postdischarge
prognosis for the followingoutcomes: first registered
nonfatal or fatal CHD event (ICD-10: I20–I25); first
registered nonfatal or fatal CVD event (any ICD-10:
I00–I99); and mortality (CHD, any CVD, non-CVD,
and total). The discharge date of the index event was
used in calculations of time to event.
Covariates
Covariates were measured at the index event and
included patients’ age, gender, health region of
residence (Southeast, West, Mid, and North), type
of healthcare delivery (acute versus not acute,
inpatient versus outpatient hospital visit), and
educational level: primary (grade school), sec-
ondary (high school/vocational school), or post-
secondary (any college or university).
Statistical analysis
Patient characteristics are reported as percent-
ages, means (standard deviation, SD), or medians
(interquartile range, IQR). The incidence of unex-
plained chest pain among persons with no previ-
ously registered chest pain or CVD diagnosis was
evaluated by gender and age groups (20–44, 45–64,
65–74, and 75–89 years of age). Cox regression
analyses evaluated hazard ratios (HR) for incident
(nonfatal or fatal) CHD and any CVD, as well as for
mortality (CHD, any CVD, non-CVD and total) in a
model containing age (years), gender, education,
and acute versus not acute healthcare (model 1).
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An additional analysis included model 1 variables
and region and type of healthcare (inpatient versus
outpatient). Results from model 2 were very similar
to those from model 1 and not presented. Time (in
days) was converted to decimal points of a year for
the Cox analyses (i.e. a mid-year event had a time
of 0.5). Schoenfeld tests evaluated Cox proportion-
ality assumptions and proportional hazard plots
for selected parameters were inspected. No devia-
tions from proportionality were identified.
Rates of subsequent CHD, any CVD and of CHD
mortality, any CVD mortality, non-CVD mortality,
and total mortality by age group and gender
were evaluated by lifetable analyses. Smoothed
hazards of mortality (per 1000 person-years) by
time (in months) postdischarge were graphed by
educational level and gender, adjusting for age
(years).
Standardized mortality ratio
The observed 1-year mortality (CHD, any CVD,
non-CVD, and total) of the patient population, 20–
89 years of age, was compared to the expected
mortality using standardized mortality ratio (SMR)
methodology based upon the 3-year (2010–2012)
average annual mortality and general population
size by gender and 5-year age intervals. The SMR
analyses were stratified by gender and age (<65
and ≥65 years).
Supplemental analyses
Supplemental analyses were conducted including
all patients discharged 2010–2012 aged 20–
89 years (n = 77 158) with a main discharge diag-
nosis of unexplained chest pain regardless of
whether they had a prior 2-year history of dis-
charge with CVD or unexplained chest pain. All
other exclusions were the same as those applied to
the primary analyses (Figure S1). The supplemen-
tal analyses included evaluation of the population-
based prevalence of discharge with unexplained
chest pain, life table analyses of mortality by age
group and gender, and SMR analyses comparing
the observed 1-year mortality of patients with that
expected based upon general population mortality
rates.
STATA 15 (Stata Corp LP, College Station, TX, USA)
and R-3.5.1 were used for the analysis of data.
Statistical significance was determined by
P ≤ 0.05.
Results
The majority of patients (86%) represented refer-
rals from out-of-hours emergency primary health-
care centres. Up to 2.3% and 2.5% of the
general population of men and women, respec-
tively, had an incident episode with a discharge
diagnosis of unexplained chest pain. Men (50.6%)
and women were nearly equally represented in
the patient population, and half of patients
(50.2%) were discharged from an in-hospital stay,
whereas the rest were discharged from outpatient
hospital clinics (Table 1). Any college or univer-
sity education was noted for 25% of the patient
population (Table 1). The geographical distribu-
tion of cases was similar to expected given
population sizes by health region (data not pre-
sented). The secondary diagnoses most often
noted at time of discharge were hypertension
(I10.0), diabetes mellitus, noninsulin dependent
(E11.9), hypercholesterolaemia (E78.0), hypothy-
roidism, unspecified (E03.9), and included a
notation for being ‘under medical observation for
cardiovascular disease’ (ICD-10 Z03.5), in that
order.
Incidence of hospital discharge with unexplained chest pain
The incidence of unexplained chest pain as pri-
mary discharge diagnosis (per 1000 residents aged
20–89 years) ranged from 11.8 to 23.0 for men and
from 8.1 to 25.3 for women. The peak incidence
rate of discharge with chest pain was 45–64 years
of age for men (light shaded bars) and 65–74 years
for women (dark shaded bars; Fig. 1).
One-year follow-up: morbidity
The majority of patients (66.9%) received cardiac
diagnostic procedures within 180 days of dis-
charge. One-year outcomes included 13 648 inci-
dent CVD cases (of whom 4479 were incident
CHD). The mean time to first CHD event (nonfatal
or fatal) was 74 days postdischarge, with age and
gender differences noted in the per cent experi-
encing a CHD event. For example, 25% (22.7–
27.4) of men and 14% (12.7–15.4) of women aged
75–89 years of age developed CHD (as diagnosis
or cause of death) within the 1-year follow-up
with lower 1-year postdischarge cumulative inci-
dences observed among the younger age groups
(Fig. 2). Compared to CHD, a greater per cent of
patients obtained any CVD outcome (diagnosis or
as cause of death) within 1-year postdischarge:
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53.0% of men and 47.6% of women aged 75–89
with lower percentages observed for younger
patients (Fig. 2).
One-year follow-up: mortality
A total of 471 deaths occurred within 1 year of
which 121 were CVD deaths (including 68 CHD
deaths) and 350 were non-CVD deaths (313
attributed to cancer). The total first-year mortality
rates (per 1000 person-years) ranged from 1.5 to
39.5 for women aged 20–44 to 75–89 years, and
from 2.7 to 69.2 for men from lowest to highest age
group, respectively (Table S2). Corresponding
rates of CVD deaths ranged from zero to 11.4 for
women and from 0.2 to 17.7 for men from lowest to
highest age group, respectively.
Differences by sex, education and acute versus nonacute care
Men had an 88% greater risk of incident CHD
adjusting for age, education, and acute care (HR
1.88; 95% CI 1.77–2.00) and a 24% greater risk of
incident total CVD (age-adjusted HR 1.24; 95% CI
1.20–1.29) compared to women (Table 2). Gender
differences were more pronounced for mortality.
Men with incident chest pain had a nearly threefold
increased risk of CVD mortality and an 87%
increased risk of non-CVD mortality compared to
women with incident chest pain (Table 2). Patients
with primary education had higher CHD and CVD
morbidity risk compared to patients with a post-
secondary education. But the educational gradi-
ents in total CVD and non-CVD mortality were
generally stronger than the educational gradient
observed for CHD and total CVD morbidity
(Table 2). Acute care patients compared to nona-
cute care patients had only modestly 4%–5%
greater hazards of incident CHD and total CVD
but a 36% and 28% greater risk of CVD and non-
CVD mortality, respectively. Additional adjustment
for healthcare type (inpatient and outpatient visits)
and health region did not modify the results
presented in Table 2.
Hazards of mortality by time postdischarge
For both men and women, hazards of total mortal-
ity (per 1000 person-years) were greatest early
postdischarge (<2 months) and declined thereafter
(Fig. 3). Hazards of mortality by time intervals
postdischarge showed a stronger educational gra-
dient in total mortality for women than men. For
men, hazards of mortality for secondary and post-
secondary education were similar but low com-
pared to the hazards associated with primary
education. The per cent of deaths attributed to
CVD was greatest in the early postdischarge time
period and then began to increase after 6 months
postdischarge (Table S1).
Standard mortality ratio
Relative to the general population, total mortality
was 53% (SMR 1.53; 95% CI 1.25–1.86) and 45%
(SMR 1.45; 95% CI 1.12–1.86) higher for men and
women under 65 years of age, respectively, attrib-
uted primarily to non-CVD causes (Table 3). For
men 65–89 years of age, a 24% higher total mor-
tality was observed relative to expected (SMR 1.24;
95% CI 1.06–1.44). In contrast, no excess mortality
was observed relative to expected for older women.
Table 1 Characteristics of patient population with main
hospital or outpatient discharge diagnosis of unexplained
chest pain, 2010–2012 (N = 59 569)
Mean (SD)
or %







Community emergency clinic referral, % 86.1
Hospitalised for index healthcare visit for
unspecified chest pain, %
50.2
Acute care patients among in-patient
hospital visits, %
47.5
Acute care patients among out-patient
hospital visits, %
26.8
Diabetesa as any secondary hospital
discharge diagnoses, %
2.1
Hypertensionb as any secondary hospital
discharge diagnosis, %
6.9
Any college/university education, % 25.0
aICD-10 diagnoses: R072–R074 among patients without
any registered CVD diagnoses or unspecified chest pain
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Supplemental analyses
In the supplemental analyses of the patient popu-
lation discharged with chest pain without the prior
health exclusions (n = 77 158), the prevalence of a
main discharge diagnosis of unexplained chest
pain (per 1000 residents) was as high at 29.4 for
men aged 45–64 years and as high as 36.2 for
women aged 65–74 years (data not presented). A
total of 865 patients died within 1-year postdis-
charge (259 CVD, 606 non-CVD of which 524 were
cancer deaths). Total mortality rates (per 1000
person-years) for women and men were similar to
that observed for the primary study population
ranging as high as 42.7 for women and 68.3 for
men aged 75–89 years (Table S2). The SMR anal-
yses found higher total mortality for younger men
and women than that expected based upon death
rates in the general population (Table 3). Older
men, however, had a lower risk of total and non-
CVD mortality but higher CVD mortality relative to
that expected in the general population. Older
women, however, had a lower risk total and non-
CVD mortality and a similar CVD mortality than
that expected based upon the general population.
Discussion
Relative to the general population, total mortality
was 53% higher for male and 45% higher for female
patients under 65 years of age where the excess
mortality was attributed primarily to non-CVD
causes. When SMR analyses included prevalent
cases of chest pain, including those with a prior
history of CVD or unexplained chest pain, we found
no strong evidence of increased CVD mortality 1-
year postdischarge relative to that expected in
younger men and in women. Older men did have
an increased risk of CVD mortality within 1 year
postdischarge than that expected based upon the
general population. Older women with unexplained
chest pain faired similarly in terms of CVD deaths,
and better than expected for total and non-CVD
mortality.
In a study of general practice patients without pre-
existing CHD, men who reported any chest pain
had higher 7-year mortality than men not reporting
any chest pain. For women, however, no differ-
ences were observed in mortality between those
reporting and not reporting any chest pain [17].
However, we observed age differences in mortality
associated with unexplained chest pain as dis-
charge diagnosis in women: significant excess
mortality was found for younger women, but not
for women 65–89 years of age who had a lower
mortality than expected. We speculate that several
underlying factors may contribute to this observa-
tion. One possibility is that older women with chest
pain are more likely to have CHD than younger
Fig. 1 Rates (per 1000
residents) of unexplained chest
pain discharge as primary
diagnosis by age and gender:
Norway, 2010–2012.
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women resulting in interventions providing health
benefits. Whereas the aetiology underlying chest
pain for younger women (as well as younger men)
is likely diverse. In fact, at younger ages, we see
little difference between men and women with
regard to non-CVD deaths and total morality.
The majority of the published literature on chest
pain focuses on cardiovascular outcomes, gastro-
oesophageal disorders, and underlying psycholog-
ical distress/anxiety. Our findings of greater non-
CVDmortality than expected within the first year of
discharge in our primary and supplementary anal-
yses suggests that patients discharged with unex-
plained chest pain may benefit from greater
healthcare coordination between medical disci-
plines.
Complaints of chest pain provide a considerable
burden to healthcare services. We found that
patients with an unexplained chest pain discharge
diagnosis during 2010–2012 represented up to
2.3% of the general population of men and 2.5% of
women in our primary analyses, and up to 2.9% of
men and 3.6% of women in selected age groups in
our supplementary analyses. Similarly, in 2017,
the number of GP contacts for complaints related
to chest pain in Norway represented 2%–4%
of the general population among those >40 years
of age (The Norwegian Directorate of Health,
Norwegian Registry for Primary healthcare, Health
Information Statistics Dashboard: https://statis
tikk.helsedirektoratet.no/bi/Dashboard/dbb5900
4-5ca1-4b16-a734-f16b88d269f7?e=false&vo=vie
wonly). Also, in the UK, approximately 2% of the
general population consult a GP for chest pain
[1,18].
Also noteworthy is that there was an approximately
20-year delay in the peak incidence of unexplained
chest pain discharge for women compared to men
in the current study. The differences in the rates
observed between men and women could reflect
differences in symptom prevalence and underlying
aetiology, healthcare seeking behaviour and refer-
ral patterns.
We also identified a high per cent of patients
obtaining follow-up diagnostic procedures within
180 days of discharge from an inpatient or out-
patient hospital visit. Subsequently, we also
found a high cumulative hazard for CHD (pri-
marily nonfatal) within the first year of follow-up:
for men and women, respectively, percentages
were as high as 25% and 14% for those 75–
89 years of age with considerable variation in 1-
year CHD and CVD prognosis by age group and
sex.
Fig. 2 Cumulative hazards (%) of incident coronary heart disease (CHD) and cardiovascular disease (CVD) (diagnosis or
death) within 1 year following discharge with unexplained chest pain as main diagnosis by age group and gender, Norway
2010–2012.
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While men compared to women had an 88% greater
hazard of CHD diagnoses (or as cause of death),
and only a 24% greater hazard of total CVD
diagnoses (or as cause of death), they had a nearly
threefold greater hazard of 1-year total CVD mor-
tality. These results would suggest that female
relative to male patients are being diagnosed with
CVD to a greater extent than CHD. The greater
CVD mortality among men, however, suggests that
men could benefit from greater follow-up postdis-
charge to identify opportunities for reducing CVD
mortality.
Comparisons with the prevailing literature are
difficult to make due to differences in study pop-
ulations, lack of age-stratified analyses, or differ-
ences in length of follow-up postdischarge. In
Iceland, two to ten per cent of unexplained chest
pain patients were diagnosed with CVD within
1 year [19]. In a study of emergency department
admissions of acute non-coronary chest pain
patients, five per cent of the patients developed
an adverse CVD event over the first year [20].
Among patients seen in rapid access chest pain
clinics in England, 32% of CHD deaths (an average
of 2.6 years from discharge) were to non-cardiac
chest pain patients [21]. Additionally, in a GP
patient follow-up study in the UK, unexplained
chest pain patients had a nearly twofold greater
risk of CVD events within 1-year postdischarge,
and a 35% increased risk of CVD within 1–3 years
of follow-up when compared to patients with an
initial diagnosis of noncoronary chest pain [22].
The high per cent developing subsequent CHD and
CVD in our study provides additional support for
the utility of follow-up diagnostic services for
patients discharged with unexplained chest pain
diagnosis.
We found stability in the educational differences in
mortality by time postdischarge for both men and
women. In contrast, in a UK study of patients who
attended their GP for chest pain, each quintile
increase in socio-economic deprivation score asso-
ciated with greater incident CHD for women but
not men [1]. As the UK and Norway both have
national healthcare systems, theoretically there
should be no differences in health coverage by
socio-economic status. Educational differences
likely exist in underlying severity of disease,
comorbidities and presence of important risk
factors at the time of presentation all of which
would contribute to the educational gradient in
mortality risks observed. The gender difference
observed in the UK and current study may relate to
different patterns of underlying risk factors by
socio-economic status and gender between the two
countries.
Strengths and limitations
A key strength is the national coverage of the data
sources of unexplained chest pain as main dis-
charge diagnosis with record linkages to subse-
quent inpatient or outpatient hospital visits and to
the Cause of Death Registry and the National
Educational Database. Another strength was the
ability to restrict analyses to a low-risk patient
population without a prior 2-year history of diag-
nosed CVD or unexplained chest pain, thereby
Fig. 3 Age-adjusted smoothed
hazards of total mortality (per
1000 person-years) within
1 year following discharge with
unexplained chest pain as
main diagnosis by educational
level and gender.
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enabling evaluation of prognosis in a largely non-
CVD patient population. A third strength is the
supplemental analyses evaluating all patients
regardless of prior history of CVD or unexplained
chest pain. Further, the study includes non-CVD
mortality as an outcome and the data sources
enabled us to compare the patient mortality expe-
rience to that of the general population. Limitations
of the current study include lack of information on
patient contacts in primary care and prescription
data. Further, as in most studies based on
administrative health registries, we lacked valida-
tion of unexplained chest pain as the main diagno-
sis, and information on individual risk factors such
as family history of CHD, blood pressure, body
mass index, blood glucose, lipid values and smok-
ing habits. Another limitation involves the under
ascertainment of secondary diagnoses precluding
the evaluation of their contribution to prognosis.
However, the sensitivity and specificity of acute
myocardial infarction as discharge diagnosis in the
Norwegian Patient Registry are acceptable [23].
Table 3 Standardized mortality ratios (SMR) of first-year mortality following a hospital discharge diagnosis of unexplained
chest pain relative to annual expected deaths based upon the general population: Norway 2010–2012
Men Women
O/E SMR (95% CI) O/E SMR (95% CI)
Incident casesa
<65 years
CVD mortalityb 23/14.9 1.55 (0.98–2.32) 4/5.2 0.77 (0.21–1.97)
Non-CVD mortality 79/51.7 1.53 (1.21–1.91) 59/38.2 1.55 (1.18–1.99)
Total mortality 102/66.5 1.53 (1.25–1.86) 63/43.3 1.45 (1.12–1.86)
65–89 years
CVD mortalityb 53/41.9 1.26 (0.95–1.65) 41/48.8 0.84 (0.60–1.14)
Non-CVD mortality 117/95.3 1.23 (1.02–1.47) 95/116.7 0.81 (0.66–0.99)
Total mortality 170/137.2 1.24 (1.06–1.44) 136/165.5 0.82 (0.69–0.97)
Men Women
O/E SMR (95% CI) c O/E SMR (95% CI) c
Prevalent casesc
<65 years
CVD mortalityb 32/23.6 1.36 (0.93–1.91) 13/8.0 1.62 (0.86–2.77)
Non-CVD mortality 106/81.0 1.31 (0.93–1.91) 88/58.6 1.50 (1.20–1.85)
Total mortality 138/104.7 1.32 (1.11–1.56) 101/66.65 1.52 (1.23–1.84)
65–89 years
CVD mortalityb 116/95.0 1.22 (1.01–1.47) 98/105.1 0.93 (0.76–1.14)
Non-CVD mortality 221/211.0 1.05 (0.09–1.20) 191/239.7 0.80 (0.69–0.92)
Total mortality 337/306.0 1.10 (0.99–1.23) 289/344.7 0.84 (0.74–0.94)
O/E, observed/expected deaths; SMR, standardized mortality ratios; CI, confidence intervals; CVD, cardiovascular
disease deaths;
aICD-10 diagnoses: R07.2–R07.4
bPatients aged 20–89 years with a main discharge diagnosis of unexplained chest pain 2010–2012 and no prior 2-year
history of unexplained chest pain or cardiovascular disease. Excludes patients without a national personal identification
number, and patients who had a secondary diagnoses of coronary heart disease (ICD-10: I20–I25) at time of discharge.
cCVD, ICD-10 diagnoses I00–I99.
dPatients aged 20–89 years with a main discharge diagnosis of unexplained chest pain 2010–2012, regardless of a prior
history of unexplained chest pain or cardiovascular disease. Excludes patients without a national personal identification
number and patients who had a secondary diagnoses of coronary heart disease (ICD-10: I20–I25) at time of discharge.
eSMR calculations of expected deaths based upon the number of deaths by gender and 5-year age strata of the general
Norwegian population aged 20–89 years.
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Conclusions
While long-term follow-up studies are needed, the
1-year prognosis suggests that patients discharged
from hospital with incident unexplained chest pain
as the main diagnosis are receiving follow-up
diagnostic evaluations but remain an at-risk
patient population where age, educational level
and gender provide indications of prognosis. Fur-
ther, given the greater 1-year non-CVD mortality
observed, better coordination between medical
disciplines in follow-up of unexplained chest pain
patients may be worthwhile.
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